Cover image of the article: Serological evaluation of anti-toxoplasma IgM and IgG antibodies in renal transplant recipient’s before and after transplant by ELFA, ELISA and ISAGA methods

Image Credit:Koomesh

Serological evaluation of anti-toxoplasma IgM and IgG antibodies in renal transplant recipient’s before and after transplant by ELFA, ELISA and ISAGA methods

Authors

Mohammad Javad Gharavi,*, Sedigheh Jalali, Shahram KhademVatan, Soudabeh Heidari
*Corresponding Author: Email: gharavi_m_j@yahoo.com

Koomesh:Vol. 13, issue 2; 177-182
Published online:Sep 25, 2012
Article type:Research Article
Received:Nov 07, 2010
How to Cite:Gharavi MJ, Jalali S, KhademVatan S, Heidari S. Serological evaluation of anti-toxoplasma IgM and IgG antibodies in renal transplant recipient’s before and after transplant by ELFA, ELISA and ISAGA methods. koomesh. 2012;13(2):e152506. doi:

Abstract

  Introduction: Toxoplasmosis is a shared human-animal disease with worldwide distribution caused by Toxoplasma gondii. More than half of the world's population is seropositive for toxoplasmosis. The possibility of reactivation of the old infection or acquisition of infection from donor’s tissue increases in the transplant recipient patients who receive immunosuppressive therapy. In this study, IgM and IgG anti-toxoplasma immunoglobulins seroconversion in renal transplant recipients was evaluated before and after transplantation.   Method: This was a prospective cohort study on a total of 102 recipients. Two serum samples were obtained from each patient. The first sample was taken before administration of any immunosuppressive drugs and second sample was taken 3 months after transplantation. The IgM and IgG anti-toxoplasma antibodies were assayed by ELFA and ELISA techniques. IgM/ISAGA method was also used.   Results: ELFA identified 65 (63.7%) pre-transplantation samples as IgG+ and did not detect any positive IgM samples. However, IgM was detected in 3 (2.9%) post-transplantation samples by this method. Forty nine (48%) pre-transplantation samples were reported IgG+ by ELISA and no IgM positive sample was identified by this method. ELISA method detected 2 (1.9%) IgM positive reactions in post-transplantation samples. By IgM/ISAGA method, we detected no IgM positive reactions in pre-transplantation samples whereas 3 months later (second sampling) IgM antibody was detected in 3 (2.9%) cases.   Conclusion: Secondary toxoplasmosis infection was observed in 30 cases per 1000 recipients, which indicates that screening for toxoplasmosis infection should be performed in developed countries for these patients. On the other hand, as the risk of re-active toxoplasmosis infection exists in developing nations, they should consider the necessary preventive measures to control this condition. In addition, we suggest that ELFA is the best method because of the most valuable results.

Highlights

Copyright

© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

19
Jun
2009
The presence of anti-Toxoplasma antibodies in 50 donors and recipients of renal transplants

The presence of anti-Toxoplasma antibodies in 50 donors and recipients of renal transplants

Mahdi Vejdani

Vejdani M. The presence of anti-Toxoplasma antibodies in 50 donors and recipients of renal transplants. J Kermanshah Univ Med Sci. 2009;13(1):e79829. doi:

1
Oct
2013
Do we Need to Screen Uremic Patients for Toxoplasmosis before Kidney Transplantation?

Do we Need to Screen Uremic Patients for Toxoplasmosis before Kidney Transplantation?

Seyed Seifollah Beladi Mousavi,
Mohammad Faramarzi

Seifollah Beladi Mousavi S, Faramarzi M. Do we Need to Screen Uremic Patients for Toxoplasmosis before Kidney Transplantation?. Shiraz E-Med J. 2013;14(4):e18283. doi: https://doi.org/10.17795/semj18283

31
Mar
2015
Screen of Uremic Patients for Toxoplasmosis Before Kidney Transplantation

Screen of Uremic Patients for Toxoplasmosis Before Kidney Transplantation

Fatemeh Hayati,
Shokouh Shayanpour

Hayati F, Shayanpour S. Screen of Uremic Patients for Toxoplasmosis Before Kidney Transplantation. Shiraz E-Med J. 2015;16(3):e26226. doi: https://doi.org/10.17795/semj26226

1
Nov
2013
Detection of Toxoplasmosis in Renal Transplant Recipients by ELISA and PCR Methods in Ahvaz, South-West of Iran

Detection of Toxoplasmosis in Renal Transplant Recipients by ELISA and PCR Methods in Ahvaz, South-West of Iran

Shahrzad Soltani,
Shahram Khademvatan,
Jasem Saki,
Heshmatollah Shahbazian

Soltani S, Khademvatan S, Saki J, Shahbazian H. Detection of Toxoplasmosis in Renal Transplant Recipients by ELISA and PCR Methods in Ahvaz, South-West of Iran. Jundishapur J Microbiol. 2013;6(9):e7642. doi: https://doi.org/10.5812/jjm.7642

13
Nov
2013
Detection of Toxoplasma gondii from Clinical Specimens of Patients Receiving Renal Transplant Using ELISA and PCR

Detection of Toxoplasma gondii from Clinical Specimens of Patients Receiving Renal Transplant Using ELISA and PCR

Morteza Izadi,
Nematollah Jonaidi Jafari,
Abbas Mahmoodzadeh Poornaki,
Javid Sadraei,
Babak Rezavand,
Hamid Reza Mirzaei
,et al.

Izadi M, Jonaidi Jafari N, Mahmoodzadeh Poornaki A, Sadraei J, Rezavand B, et al. Detection of Toxoplasma gondii from Clinical Specimens of Patients Receiving Renal Transplant Using ELISA and PCR. Nephro-Urol Mon. 2013;5(5):983-987. doi: https://doi.org/10.5812/numonthly.13657

More by these authors

Mohammad Javad GharaviPubMedScholar
Sedigheh JalaliPubMedScholar
Shahram KhademVatanPubMedScholar
Soudabeh HeidariPubMedScholar
Share
Cited by
Metrics